Attitudes towards COVID Vaccine and Vaccine Hesitancy in Dermatology: A Narrative Review.

Woo Chiao Tay, Anthony Bewley, Julia-Tatjana Maul, Hazel H Oon
Author Information
  1. Woo Chiao Tay: National Skin Centre, 1 Mandalay Road, Singapore 308205, Singapore. ORCID
  2. Anthony Bewley: Department of Dermatology, Barts Health NHS Trust, London E11 1NR, UK.
  3. Julia-Tatjana Maul: Department of Dermatology and Venereology, University Hospital of Zurich, 8091 Zurich, Switzerland. ORCID
  4. Hazel H Oon: National Skin Centre, Skin Research Institute of Singapore, 1 Mandalay Road, Singapore 308205, Singapore. ORCID

Abstract

Vaccine hesitancy has been a contentious issue even before the pandemic. The COVID-19 crisis has further amplified vaccine hesitancy, with worries about adverse effects, cultural and religious beliefs, and misinformation on social media. In dermatology, patients with pre-existing skin conditions may have specific concerns about the impact of the vaccine on their skin health. Factors such as cutaneous reactions, potential flares of underlying conditions, and fears of psoriasis worsening post-vaccination contribute to vaccine hesitancy. Healthcare professionals, including dermatologists, play a crucial role in addressing vaccine hesitancy by providing accurate information, addressing concerns, and understanding the psychological impact on patients. The concept of vaccine fatigue is also explored, noting the challenges in sustaining vaccine acceptance over time, especially with regards to booster vaccinations. Overcoming vaccine hesitancy requires trust-building, effective communication strategies, and collaboration between healthcare workers and non-healthcare individuals to combat misinformation. By recognizing and addressing psychological factors, dermatologists can increase vaccine acceptance and improve public health efforts.

Keywords

References

  1. Br J Dermatol. 2022 Aug;187(2):254-256 [PMID: 35104366]
  2. Int J Dermatol. 2020 Sep;59(9):1043-1056 [PMID: 32621284]
  3. Health Psychol Res. 2022 Apr 26;10(3):34218 [PMID: 35774910]
  4. J Med Virol. 2022 Jun;94(6):2369-2375 [PMID: 35028946]
  5. Vaccine. 2018 Aug 6;36(32 Pt B):4875-4879 [PMID: 29980390]
  6. N Engl J Med. 2020 May 21;382(21):1969-1973 [PMID: 32227757]
  7. Nat Commun. 2022 Mar 28;13(1):1614 [PMID: 35347129]
  8. Vaccines (Basel). 2022 Mar 17;10(3): [PMID: 35335096]
  9. J Community Health. 2022 Jun;47(3):519-529 [PMID: 35277813]
  10. Health Expect. 2021 Aug;24(4):1158-1167 [PMID: 33942948]
  11. J Sex Med. 2013 Oct;10(10):2455-64 [PMID: 23745833]
  12. Sci Rep. 2022 Aug 11;12(1):13681 [PMID: 35953500]
  13. Nat Hum Behav. 2020 May;4(5):460-471 [PMID: 32355299]
  14. J Drugs Dermatol. 2022 Aug 1;21(8):901-905 [PMID: 35946967]
  15. Nat Hum Behav. 2021 Mar;5(3):337-348 [PMID: 33547453]
  16. Public Health. 2022 Jun;207:94-104 [PMID: 35594808]
  17. Br J Dermatol. 2021 Jul;185(1):209-210 [PMID: 33609286]
  18. Public Health. 2021 Dec;201:98-107 [PMID: 34801843]
  19. Nat Hum Behav. 2020 Jul;4(7):677-687 [PMID: 32581299]
  20. Front Immunol. 2022 Mar 10;13:839433 [PMID: 35359948]
  21. Br J Dermatol. 2023 Aug 24;189(3):351-353 [PMID: 37210215]
  22. Vaccine. 2021 Sep 24;39(40):5737-5740 [PMID: 34456072]
  23. Am J Infect Control. 2022 Jan;50(1):20-25 [PMID: 34653527]
  24. Wkly Epidemiol Rec. 2012 Jan 6;87(1):1-16 [PMID: 22242233]
  25. J Drugs Dermatol. 2019 Jan 01;18(1):18-22 [PMID: 30681788]
  26. Infect Control Hosp Epidemiol. 2022 Dec;43(12):1813-1821 [PMID: 35156600]
  27. Vaccine. 2015 Aug 14;33(34):4180-90 [PMID: 25896377]
  28. SN Compr Clin Med. 2021;3(11):2214-2221 [PMID: 34568763]
  29. Medicine (Baltimore). 2022 Jul 29;101(30):e29786 [PMID: 35905271]
  30. J Invest Dermatol. 2019 Feb;139(2):473-475 [PMID: 30315780]
  31. Ann Dermatol Venereol. 2017 Feb;144(2):92-99 [PMID: 27771122]
  32. Vaccines (Basel). 2021 Dec 06;9(12): [PMID: 34960183]
  33. Glob Health Sci Pract. 2022 Mar 1;10(1): [PMID: 35294395]
  34. BMJ Glob Health. 2020 Oct;5(10): [PMID: 33097547]
  35. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  36. Bull World Health Organ. 2008 Feb;86(2):140-6 [PMID: 18297169]
  37. N Engl J Med. 2022 Jul 7;387(1):58-65 [PMID: 35767527]
  38. Nature. 2021 Sep;597(7878):606-607 [PMID: 34548661]
  39. Soc Sci Med. 2020 Oct;263:113356 [PMID: 32967786]
  40. Vaccine. 2005 Feb 18;23(13):1574-8 [PMID: 15694509]
  41. Vaccine. 2016 Dec 20;34(52):6700-6706 [PMID: 27810314]
  42. J Med Internet Res. 2009 Nov 27;11(4):e48 [PMID: 19945947]
  43. Vaccines (Basel). 2021 Feb 16;9(2): [PMID: 33669441]
  44. Health Promot Int. 2022 Jun 1;37(3): [PMID: 35788306]
  45. Vaccines (Basel). 2022 Apr 28;10(5): [PMID: 35632445]
  46. Vaccine. 2020 Jul 14;38(33):5131-5138 [PMID: 32409135]
  47. Vaccine. 2014 Apr 17;32(19):2150-9 [PMID: 24598724]
  48. Clin Cosmet Investig Dermatol. 2022 Nov 06;15:2369-2382 [PMID: 36387962]
  49. Lancet Respir Med. 2018 Feb;6(2):94-95 [PMID: 29169772]
  50. Sci Transl Med. 2019 Jun 19;11(497): [PMID: 31217336]
  51. BMC Public Health. 2022 Jan 18;22(1):120 [PMID: 35039009]
  52. Int J Nurs Stud. 2011 Oct;48(10):1281-9 [PMID: 21474136]
  53. Vaccines (Basel). 2021 Jun 01;9(6): [PMID: 34205935]
  54. Z Rheumatol. 2018 Oct;77(8):727-734 [PMID: 29236153]
  55. Am J Public Health. 2008 Feb;98(2):244-53 [PMID: 18172138]
  56. Arch Dermatol Res. 2023 Aug;315(6):1583-1592 [PMID: 36749390]
  57. Front Pediatr. 2022 Nov 24;10:950406 [PMID: 36507133]
  58. Vaccines (Basel). 2022 Mar 21;10(3): [PMID: 35335113]
  59. JAMA Netw Open. 2022 Aug 1;5(8):e2228061 [PMID: 35994284]
  60. BMJ Glob Health. 2022 Mar;7(3): [PMID: 35264318]
  61. Nat Med. 2023 May;29(5):1164-1171 [PMID: 36973410]
  62. Ir J Med Sci. 2022 Feb;191(1):71-80 [PMID: 33990893]
  63. Int J Clin Pract. 2021 Oct;75(10):e14666 [PMID: 34322977]
  64. Vaccine. 2012 Aug 24;30(39):5703-7 [PMID: 22828586]
  65. BMC Prim Care. 2022 Apr 15;23(1):81 [PMID: 35421920]
  66. J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e132-e134 [PMID: 36268687]
  67. J Med Internet Res. 2015 Jun 10;17(6):e144 [PMID: 26063290]
  68. Vaccine. 2023 Jan 4;41(1):136-144 [PMID: 36411132]
  69. Rheumatology (Oxford). 2023 Oct 3;62(10):3291-3301 [PMID: 36734536]
  70. Hum Vaccin Immunother. 2022 Dec 31;18(1):1950504 [PMID: 34325612]
  71. J Dtsch Dermatol Ges. 2013 Sep;11(9):837-44 [PMID: 23957483]
  72. Science. 2022 Mar 11;375(6585):1127-1132 [PMID: 35271316]
  73. Hum Vaccin Immunother. 2021 Sep 2;17(9):2962-2964 [PMID: 33890838]
  74. Hum Vaccin Immunother. 2021 Nov 2;17(11):4105-4107 [PMID: 34597526]
  75. Infect Dis Ther. 2022 Oct;11(5):2045-2061 [PMID: 36094720]
  76. Clin Dermatol. 2021 Jul-Aug;39(4):674-687 [PMID: 34809772]
  77. J Psoriasis Psoriatic Arthritis. 2022 Jan;7(1):17-23 [PMID: 39296733]
  78. Patient Educ Couns. 2017 Jul;100(7):1280-1286 [PMID: 28209248]
  79. Vaccines (Basel). 2022 May 30;10(6): [PMID: 35746481]
  80. Vaccines (Basel). 2022 Jul 08;10(7): [PMID: 35891265]
  81. JAMA Netw Open. 2021 Sep 1;4(9):e2126882 [PMID: 34559232]
  82. Hum Vaccin Immunother. 2013 Aug;9(8):1763-73 [PMID: 23584253]
  83. J Allergy Clin Immunol Pract. 2023 Mar;11(3):958-960 [PMID: 36581074]
  84. Vaccines (Basel). 2022 Mar 30;10(4): [PMID: 35455286]
  85. Br J Soc Psychol. 2001 Dec;40(Pt 4):471-99 [PMID: 11795063]
  86. Am J Clin Dermatol. 2022 Sep;23(5):729-737 [PMID: 35931925]
  87. J Allergy Clin Immunol Glob. 2023 May;2(2):100079 [PMID: 36785543]
  88. J Am Assoc Nurse Pract. 2019 Nov;31(11):624-626 [PMID: 31688502]
  89. Br J Dermatol. 2022 Apr;186(4):737-739 [PMID: 34842282]

Word Cloud

Created with Highcharts 10.0.0vaccinehesitancyhealthVaccineskinaddressingmisinformationsocialpatientsconditionsconcernsimpactdermatologistspsychologicalacceptancecontentiousissueevenpandemicCOVID-19crisisamplifiedworriesadverseeffectsculturalreligiousbeliefsmediadermatologypre-existingmayspecificFactorscutaneousreactionspotentialflaresunderlyingfearspsoriasisworseningpost-vaccinationcontributeHealthcareprofessionalsincludingplaycrucialroleprovidingaccurateinformationunderstandingconceptfatiguealsoexplorednotingchallengessustainingtimeespeciallyregardsboostervaccinationsOvercomingrequirestrust-buildingeffectivecommunicationstrategiescollaborationhealthcareworkersnon-healthcareindividualscombatrecognizingfactorscanincreaseimprovepubliceffortsAttitudestowardsCOVIDHesitancyDermatology:NarrativeReviewmentalpsychodermatologyisolationvaccinessafety

Similar Articles

Cited By (1)